These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 18586005
1. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells. Kim DJ, Lee DC, Yang SJ, Lee JJ, Bae EM, Kim DM, Min SH, Kim SJ, Kang DC, Sang BC, Myung PK, Park KC, Yeom YI. Biochem Biophys Res Commun; 2008 Sep 05; 373(4):521-7. PubMed ID: 18586005 [Abstract] [Full Text] [Related]
2. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI. Gastroenterology; 2010 May 05; 138(5):1898-908. PubMed ID: 20038433 [Abstract] [Full Text] [Related]
3. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Moore LD, Isayeva T, Siegal GP, Ponnazhagan S. Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771 [Abstract] [Full Text] [Related]
4. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Uttamsingh S, Bao X, Nguyen KT, Bhanot M, Gong J, Chan JL, Liu F, Chu TT, Wang LH. Oncogene; 2008 Apr 17; 27(18):2626-34. PubMed ID: 17982486 [Abstract] [Full Text] [Related]
5. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells. Kwok S, Rittling SR, Partridge NC, Benson CS, Thiyagaraj M, Srinivasan N, Selvamurugan N. J Cell Biochem; 2009 Oct 01; 108(2):408-14. PubMed ID: 19582787 [Abstract] [Full Text] [Related]
6. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S, Zhang F, Miao L, Zhang H, Fan Z, Wang X, Ji G. Oncol Rep; 2008 Nov 01; 20(5):1053-9. PubMed ID: 18949401 [Abstract] [Full Text] [Related]
7. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases. Takayama S, Hatori M, Kurihara Y, Kinugasa Y, Shirota T, Shintani S. Oncol Rep; 2009 Jan 01; 21(1):205-10. PubMed ID: 19082463 [Abstract] [Full Text] [Related]
9. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells. Yeh MH, Kao ST, Hung CM, Liu CJ, Lee KH, Yeh CC. Toxicol Lett; 2009 Feb 10; 184(3):204-10. PubMed ID: 19110045 [Abstract] [Full Text] [Related]
10. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell. Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS. J Gastroenterol Hepatol; 2010 Feb 10; 25(2):420-6. PubMed ID: 19793165 [Abstract] [Full Text] [Related]
12. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG. Mol Cell Biol; 2007 Jun 10; 27(12):4488-99. PubMed ID: 17438144 [Abstract] [Full Text] [Related]
13. Direct activation of TGF-beta1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice. Yoon G, Kim JY, Choi YK, Won YS, Lim IK. J Cell Biochem; 2006 Feb 01; 97(2):393-411. PubMed ID: 16187311 [Abstract] [Full Text] [Related]
14. Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer. Weise JB, Csiszar K, Gottschlich S, Hoffmann M, Schmidt A, Weingartz U, Adamzik I, Heiser A, Kabelitz D, Ambrosch P, Görögh T. Int J Oncol; 2008 Feb 01; 32(2):317-22. PubMed ID: 18202753 [Abstract] [Full Text] [Related]
15. Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma. Görögh T, Weise JB, Holtmeier C, Rudolph P, Hedderich J, Gottschlich S, Hoffmann M, Ambrosch P, Csiszar K. J Pathol; 2007 May 01; 212(1):74-82. PubMed ID: 17354256 [Abstract] [Full Text] [Related]
16. Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells. Kirwan RP, Leonard MO, Murphy M, Clark AF, O'Brien CJ. Glia; 2005 Dec 01; 52(4):309-24. PubMed ID: 16078232 [Abstract] [Full Text] [Related]
17. Transcriptional regulation of the TGF-beta1 promoter by androgen receptor. Qi W, Gao S, Wang Z. Biochem J; 2008 Dec 15; 416(3):453-62. PubMed ID: 18651839 [Abstract] [Full Text] [Related]
18. TGF-beta1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-beta1-enhanced cell migration in SMMC-7721 cells. Xu Z, Shen MX, Ma DZ, Wang LY, Zha XL. Cell Res; 2003 Oct 15; 13(5):343-50. PubMed ID: 14672557 [Abstract] [Full Text] [Related]
19. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1. Herzer K, Grosse-Wilde A, Krammer PH, Galle PR, Kanzler S. Mol Cancer Res; 2008 Jul 15; 6(7):1169-77. PubMed ID: 18644981 [Abstract] [Full Text] [Related]
20. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K, Matsuhashi S. Oncogene; 2006 Oct 05; 25(45):6101-12. PubMed ID: 16682950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]